Implantica AG (FRA:8IM1)

Germany · Delayed Price · Currency is EUR

5.29

+0.42 (8.74%)

Last updated: Aug 26, 2026, 9:12 AM CET

-19.85% (1Y)

Market Cap	1.49B -21.2%
Revenue (ttm)	2.47M +25.7%
Net Income	-19.72M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	5.29
Previous Close	4.87
Day's Range	5.29 - 5.29
52-Week Range	3.62 - 6.59
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland and Spain. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system monitor, transmit, and actively treat conditions from within the body; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagno... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2015

Employees 46

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 8IM1

Full Company Profile

Financial Performance

In 2025, Implantica AG's revenue was 2.07 million, an increase of 7.08% compared to the previous year's 1.94 million. Losses were -19.63 million, -15.89% less than in 2024.

Financial Statements